The role of pre-emptive re-transplant in graft and recipient outcome

Nephrology Dialysis Transplantation

Volumn 21, Issue 5, 2006, Pages 1355-1364

  Goldfarb Rumyantzev, Alexander S ^a,e   Hurdle, John F ^a   Baird, Bradley C ^a   Stoddard, Greg ^a   Wang, Zhi ^a   Scandling, John D ^b   Barenbaum, Lev L ^c   Cheung, Alfred K ^a,d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RenalServicecom Inc   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Pre emptive transplant; Re transplant; Transplant graft survival; Transplant recipient survival

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ARTICLE; CADAVER DONOR; DATA ANALYSIS; DEATH; DIABETES MELLITUS; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVING DONOR; MEDICAL RECORD REVIEW; MORTALITY; PANCREAS TRANSPLANTATION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REOPERATION; RISK ASSESSMENT; TIME; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; REOPERATION; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; WAITING LISTS;

EID: 33646195752     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfk061     Document Type: Article

References (19)

1. Ojo AO, Hanson JA, Meier-Kriesche HU et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12: 589-597
2. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi B. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590
3. Ojo AO, Wolfe RA, Agodoa LY et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation. Multivariate analyses from the United States Renal Data System. Transplantation 1998; 66: 1651-1659
4. Ojo A, Wolfe RA, Agodoa LY et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation 1998; 66: 1651-1659
5. Goldfarb-Rumyantzev A, Hurdle JF, Scandling J et al. Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant 2005; 20: 167-175
6. Kasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT. Preemptive kidney transplantation: The advantage and the advantaged. J Am Soc Nephrol 2002; 13: 1358-1364
7. Meier-Kriesche HU, Port FK, Ojo AO et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58: 1311-1317
8. Goldfarb-Rumyantzev AS, Scandling JD, Pappas L, Smout RJ, Horn S. Prediction of 3-yr cadaveric graft survival based on pre-transplant variables in a large national dataset. Clin Transplant 2003; 17: 485-497
9. Gjertson DW. Determinants of long-term survival of adult kidney transplants: A 1999 UNOS update, in Clin Transplants 1999, Los Angeles, UCLA Immunogenetics Center, 2000, pp. 341-352
10. Meier-Kriesche H, Port FK, Ojo AO et al. Deleterious effect of waiting time on renal transplant outcome. Transplant Proc 2001; 33: 1204-1206
11. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI. Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: Their interrelationship and prediction of survival. Am J Kidney Dis 1995; 26: 353-361
12. Hariharan S. Long-term kidney transplant survival. Am J Kidney Dis 2001; 38: S44-S50
13. Mange KC, Joffe MM, Feldman HI. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N Engl J Med 2001; 344: 726-731
14. Veller MG, Botha JR, Seggie J, Thomson PD, Meyers AM, Myburgh JA. Renal retransplantation. The Johannesburg Hospital experience. S Afr Med J 1987; 71: 752-754
15. Gjertson DW. A multi-factor analysis of kidney regraft outcomes. Clin Transpl 2002; 335-349
16. Cooper AC, Mikhail A, Lethbridge MW, Kemeny DM, Macdougall IC. Increased expression of erythropoiesis inhibiting cytokines (IFN-gamma, TNF-alpha, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol 2003; 14: 1776-1784
17. Libetta C, Rampino T, Dal Canton A. Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients. Am J Kidney Dis 2001; 38: 286-295
18. Nishimoto A, Matsumoto Y. Increase of peripheral natural killer T cells in hemodialysis patients. Clin Nephrol 2001; 55: 121-126
19. Yokoyama T, Nitta K, Futatsuyama K et al. Identification of T helper cell subsets in continuous ambulatory peritoneal dialysis patients. Nephron 2001; 89: 215-218